naturally occuring agent produced by a microbe that inhibits or kills another.
selective toxicity
agent being used should inhibit or kill the intended pathogen without seriously harming the host
empiric therapy
treatment of an infection before specific cultureinformation has been obtained
targeted therapy
treatment focused to known pathogen and susceptibility
prophaylactic therapy
administration of an antibiotic to prevent infection
bacteriostatic
inhibit the growth of susceptible bacteria rather than killing them immediately. Eventually leads to bacterial death.Immune defence plays a role in clearing the pathogen
bactericidal
kills susceptible bacteria. Important to use for immunocompromised patients and certain difficult infections
Narrow spectrum antibiotics
active against specific organisms, not causing damage to the normal flora
Broad spectrum antibiotic
active against manybacteria
MIC
minimum inhibitory concentration
two methods for susceptibility testing
disk diffusion and minimum inhibitory concentration
goals of antimicrobial stewardship
imporve patientoutcomes, improve pateint safety, reduce resistance, reduce healthcare cost without compromising patient care
COMS
clinical improvement, oral route is not compromised, markers are trending down, specific indication
prophylaxis
treatment given or action taken to prevent disease
adverse effects of antibiotics
allergy - penicillin, altered normal flora, drug interactions, specific organ toxicity, antibiotic resistance
what enzyme catalyses the builiding of cross linked chains?
beta-lactams bind directly to transpeptidase preventing cross linking, bactericida
four main types of beta-lactams
penicillins
cephalosporins
carbapenems
monobactams
what enzyme catalyses the cross-linking of the cell wall peptides?
transpeptidase, also known as penicillin-binding protein
what antibiotics target transpeptidase?
penicillin and other beta-lactams
how do bata-lactam anitbiotics target transpeptidase?
bind irreversibly to its active site. binding inhibits transpeptidase activity, prevents formation of cross-links between peptidoglycan strands. bacterial cell wall synthesis is disrupted, leading to weaked cell wall and eventual cell lysis. bactericidal.
cell lysis
cell death
penicillinase-producing staphylococci
penicillinase destroys penicilln and stops it from being an effective treatment
penicillin is highly active against
gram-positive cocci, gram-positive rods (listeria), most anaerobes, gram-negatives
penicillin therapeutic use
endocarditis, meningitis and pneumonia caused by susceptible bacteria. cellulitis and groupA strep infections. And Syphilis (gram neg)
anti-staphylococcal penicillins are active against
penicillinase-producing staphylococci. ex: flucloxacillin (oral or IV)
therapeutic use of anti-staphylococcal penicillins
endocarditis and BSI caused by staphylococci and septic arthritis caused by S. aureus
anti-staphylococcal penicillins do not protect against MRSA, enterococci or Listeria
penicillin G
IM and IV
Penicillin V
acid stable so it can be given via the oral route
co-amoxiclav is augementin with clavulanate
inhibits Beta-lactamases so that amoxicillin remains active
pip-tazo (IV only) tazobactam
inhibts beta-lactamases of MRSA so that piperacillin remains active
therapeutic use of borad spectrum penicillins with gram-positive activity
provide cover for gram-positives in treatment of infections with mixed aetiologies.combination antibiotics
vancomycin no good for gram-negatives
flucloxacillin no use for MRSA
cephalosporins (generally broad spectrum)
1st gen cephalosporins
good gram-pos activity, also some gram-neg activity
oral
respiratory infections and UTIs
2nd gen cephalosporins
gram pos and neg activity
oral and IV
respiratory infections, complicated UTIs and surgical prophylaxis
ex: cefuroxime
surgical prophylaxis
the use of antibiotics for the prevention of surgical site infections
3rd gen cephalosporins
good gram-neg activity
less staphylococcal activity + some streptococcal activity